PAVmed (PAVM) Stock Analysis: AI Score & Alternative Data
PAVM alt-data: web traffic climbing, business outlook lagging
Is PAVmed a buy right now? The alternative data leans no. This PAVM stock analysis is built on the 25+ alternative data signals AltIndex tracks on PAVmed every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 35/100: a Sell. The stock trades at $2.68 with a $21M market cap.
The 90-day pressure points: just 48% of employees report a positive business outlook. There are bright spots — web traffic up 32.0% to 4K monthly visits — but not enough to offset the broader weakness.
PAVM’s broader alt-data profile also covers headcount (39 employees, according to LinkedIn), X followers (1K), Reddit mentions (1 a day), and sentiment (100/100). Every signal links to its own page with full history, the PAVM technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on PAVM is just below.
PAVmed AI Stock Analysis
PAVmed Inc. operates as a medical device company in the United States. It offers a broad spectrum of products aimed at addressing unmet clinical needs in various fields like diagnostics, infusion therapy, and surgical tools. While the company's mission is innovative, recent financial disclosures and market activity provide a mixed view of its current health and trajectory.
Analysis generated October 2, 2026.
Recent PAVmed Stock Alerts
|
PAVmed | October 5 Price is down by -6.3% in the last 24h. |
|
PAVmed | October 2 Price is up by 10.4% in the last 24h. |
|
PAVmed | October 1 Price is down by -6.5% in the last 24h. |
|
PAVmed | September 29 Price is up by 7.3% in the last 24h. |
PAVmed Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 4K | 32.0% | |
| Job Posts | 0 | 100.0% | |
| LinkedIn Employees | 39 | 2.6% | |
| Employee Recommend | 48 | 0% | |
| Business Outlook | 48 | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 1 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 13 | 116.7% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 9K | 0.7% | |
| X Followers | 1K | 0.6% | |
| Youtube Subscribers | 262 | 0% |
About PAVmed (PAVM)
PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.
| Price | $2.68 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $21M |
| Year Range | $3 – $17 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest PAVmed News
View more → |
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial ResultsAugust 14 - PRNewswire |
 |
PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026July 31 - PRNewswire |
 |
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA TestAugust 5 - PRNewswire |
 |
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026July 30 - PRNewswire |
Gastrointestinal Collaboration and Licensing Agreements Benchmark Report 2026: Access to Structured Analysis of 432 Deals Signed Since 2016 - Finance, Indications, Modalities, Stages of DevelopmentMay 19 - GlobeNewswire |
See PAVmed’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for PAVM, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEPAVmed Earnings & Financial Performance
View all earnings →PAVmed Insider Trading Activity
View all →| No recent insider transactions on file. |
PAVmed Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to PAVmed
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Modular MedicalMODD |
$2.73 18.7% | $22M | 49 |
 |
Inspira TechnologiesIINN |
$0.38 2.1% | $17M | 46 |
 |
SINTX TechnologiesSINT |
$2.18 0.0% | $15M | 50 |
 |
CytoSorbentsCTSO |
$3.96 0.1% | $12M | 46 |
 |
IridexIRIX |
$0.68 1.5% | $12M | 43 |
Explore PAVmed Data
Frequently Asked Questions: PAVmed (PAVM)
PAVmed has an AltIndex AI Score of 35/100 (Sell). The score reflects negative alternative data signals. All investments carry risk.
35/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of PAVmed (PAVM) stock is $2.68 with a market cap of $21M.
As of today, PAVmed’s PE (Price to Earnings) ratio is —.
View the latest PAVmed insider transactions to see recent buying and selling activity by company executives and directors.
Check the PAVmed congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The PAVM stock price chart above shows PAVmed’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full PAVmed technical analysis for RSI, moving averages, and more.
See the stocks similar to PAVmed section on this page for companies in the same industry ranked by market cap and AI Score.
